Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
34.22
-0.76 (-2.17%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Rigel Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts that cover Rigel Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $38.2, which forecasts a 11.63% increase in the stock price over the next year. The lowest target is $23 and the highest is $57.
Price Target: $38.2 (+11.63%)
Analyst Consensus: Buy
* Price targets were last updated on Aug 6, 2025.
Analyst Ratings
The average analyst rating for Rigel Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $23 → $32 | Hold | Maintains | $23 → $32 | -6.49% | Aug 6, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $20 → $23 | Hold | Maintains | $20 → $23 | -32.79% | May 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $49 → $55 | Strong Buy | Maintains | $49 → $55 | +60.72% | Mar 6, 2025 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $20 → $24 | Hold | Maintains | $20 → $24 | -29.87% | Mar 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +66.57% | Mar 5, 2025 |
Financial Forecast
Revenue This Year
286.72M
from 179.28M
Increased by 59.93%
Revenue Next Year
282.55M
from 286.72M
Decreased by -1.45%
EPS This Year
5.67
from 0.99
Increased by 472.64%
EPS Next Year
3.85
from 5.67
Decreased by -32.05%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 304.8M | 363.7M | |||
| Avg | 286.7M | 282.6M | |||
| Low | 269.5M | 228.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 70.0% | 26.9% | |||
| Avg | 59.9% | -1.5% | |||
| Low | 50.3% | -20.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.28 | 6.07 | |||
| Avg | 5.67 | 3.85 | |||
| Low | 4.99 | 2.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 534.2% | 7.1% | |||
| Avg | 472.6% | -32.0% | |||
| Low | 403.9% | -63.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.